l-carnitine mitochondria Targeting Skeletal Muscle Dysfunction With for the Treatment of Patients With Chronic Obstructive Pulmonary Disease L-Carnitine | Linus Pauling Institute
Description
-L., Piper, M

We take responsibility

M., Wang L., Naviaux R
Around 60% of infants with pathogenic variants in the MMAA or MMAB genes present with symptoms after the first month of life
Skeletal muscle adaptations and post-exertional malaise in long COVID Understanding Muscle Dysfunction in Chronic Fatigue Syndrome Clinical efficacy of L-carnitine in the management of post-COVID-19 syndrome Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update Metabolic signature in nucleus accumbens for anti-depressant-like effects of acetyl-L-carnitine

Toptas, B., Baykal, A., Yesilipek, A., Isbir, M., Kupesiz, A., Yalcin, O., and Baskurt, O
